Location: Paris, France
CIK: 0001757283 · Show all filings
Period: Q3 2026 (← Previous)
Filing Date: Oct 16, 2026
Total Value: $176M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| ABVX | ABIVAX SA | 78,125 | $10.41M | 5.9% | $133.26 * | $109.11 | -9.2% | — | 00370M103 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| EVMN | EVOMMUNE INC | 97,362 (-93.0%) | $804K (-95.7%) | 0.5% | $8.26 | $18.78 | -56.0% | COM SHS | 30054Y107 |
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| KMTS | KESTRA MED TECHNOLOGIES LTD | 2,728,679 | $77.19M | 43.9% | $28.29 | $25.57 | +10.6% | SHS | G52441105 |
| AVLN | AVALYN PHARMACEUTICALS INC | 929,824 | $26.49M | 15.1% | $28.49 | $28.86 | -1.3% | COM SHS | 05348Y105 |
| MLYS | MINERALYS THERAPEUTICS INC | 1,591,917 | $40M | 22.8% | $25.13 | $40.10 | -37.3% | COM | 603170101 |
| AGMB | AGOMAB THERAPEUTICS NV | 1,538,702 | $17.08M | 9.7% | $11.10 | $14.16 | -21.6% | SPONSORED ADS | 00860C102 |
| IVA | INVENTIVA SA | 3,633,181 | $13.41M | 7.6% | $3.69 | $4.73 | -21.9% | ADS | 46124U107 |
| NYXH | NYXOAH S A | 522,057 | $720K | 0.4% | $1.38 | $4.22 | -67.3% | SHS | B6S7WD106 |